Back
ITeos Therapeutics Vs. Bowman Consulting Group Industry Stock Comparison
Sell
30
ITOS
ITeos Therapeutics
Last Price:
10.81
Seasonality Move:
-2.62%
Sell
38
BWMN
Bowman Consulting Group
Last Price:
32.87
Seasonality Move:
-5.05%
Sell
30
ITeos Therapeutics (ITOS)
is a Sell
Is ITeos Therapeutics a Buy, Sell or Hold?
- The current ITeos Therapeutics [ITOS] share price is $10.80. The Score for ITOS is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- ITOS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Bowman Consulting Group (BWMN)
is a Sell
Is Bowman Consulting Group a Buy, Sell or Hold?
- The current Bowman Consulting Group [BWMN] share price is $32.95. The Score for BWMN is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- BWMN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ITOS Stock Price Chart
What is ITeos Therapeutics's stock price today?
-
The ITeos Therapeutics share price today is $10.80
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITOS is experiencing slight buying pressure.
BWMN Stock Price Chart
What is Bowman Consulting Group's stock price today?
-
The Bowman Consulting Group share price today is $32.95
The current trend is relatively stagnant and BWMN is experiencing buying pressure, which is a positive indicator for future bullish movement.
ITOS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.3 | Sell |
| Relative Strength Index (14 RSI): | 43.65 | Sell |
| Chaikin Money Flow: | 60303 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.82 - 12.78) | Sell |
| Bollinger Bands (100): | (10.16 - 11.82) | Sell |
BWMN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.97 | Sell |
| Relative Strength Index (14 RSI): | 50.62 | Buy |
| Chaikin Money Flow: | 64449 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.15 - 35.93) | Sell |
| Bollinger Bands (100): | (30.95 - 36.57) | Sell |
ITOS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.67 | Buy |
| 20-day SMA: | 11.66 | Sell |
| 50-day SMA: | 11.38 | Sell |
| 200-day SMA: | 11.17 | Sell |
| 8-day EMA: | 10.86 | Sell |
| 20-day EMA: | 11.27 | Sell |
| 50-day EMA: | 11.31 | Sell |
| 200-day EMA: | 11.9 | Sell |
BWMN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.17 | Buy |
| 20-day SMA: | 31.78 | Buy |
| 50-day SMA: | 34.47 | Sell |
| 200-day SMA: | 31.57 | Buy |
| 8-day EMA: | 31.73 | Buy |
| 20-day EMA: | 32.39 | Buy |
| 50-day EMA: | 33.47 | Sell |
| 200-day EMA: | 31.57 | Buy |
ITeos Therapeutics Earnings Growth & ITOS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.65 per share, a decrease this year of $1.02 per share, and a decrease next year of $1.35 per share.
Bowman Consulting Group Earnings Growth & BWMN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.14 per share, an increase this year of $0.61 per share, and an increase next year of $0.38 per share.
ITeos Therapeutics Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bowman Consulting Group Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||